BlackRock’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,813,602
Closed -$30.9M 5164
2020
Q3
$30.9M Sell
9,813,602
-148,332
-1% -$467K ﹤0.01% 2539
2020
Q2
$29M Buy
9,961,934
+5,182
+0.1% +$15.1K ﹤0.01% 2566
2020
Q1
$28.1M Sell
9,956,752
-818,250
-8% -$2.31M ﹤0.01% 2393
2019
Q4
$35M Sell
10,775,002
-310,726
-3% -$1.01M ﹤0.01% 2546
2019
Q3
$23.9M Buy
11,085,728
+31,238
+0.3% +$67.5K ﹤0.01% 2693
2019
Q2
$34.7M Sell
11,054,490
-1,294,598
-10% -$4.07M ﹤0.01% 2518
2019
Q1
$45.9M Sell
12,349,088
-237,665
-2% -$884K ﹤0.01% 2314
2018
Q4
$36.5M Buy
12,586,753
+71,710
+0.6% +$208K ﹤0.01% 2402
2018
Q3
$32.9M Sell
12,515,043
-1,503,409
-11% -$3.95M ﹤0.01% 2582
2018
Q2
$32.8M Sell
14,018,452
-574,932
-4% -$1.35M ﹤0.01% 2577
2018
Q1
$42.9M Sell
14,593,384
-118,579
-0.8% -$349K ﹤0.01% 2351
2017
Q4
$40.3M Buy
14,711,963
+713,150
+5% +$1.95M ﹤0.01% 2403
2017
Q3
$47.5M Sell
13,998,813
-785,697
-5% -$2.66M ﹤0.01% 2312
2017
Q2
$36.5M Buy
14,784,510
+399,864
+3% +$988K ﹤0.01% 2428
2017
Q1
$32.7M Buy
14,384,646
+14,327,235
+24,956% +$32.5M ﹤0.01% 2456
2016
Q4
$122K Sell
57,411
-86,111
-60% -$183K ﹤0.01% 2379
2016
Q3
$480K Buy
143,522
+6,072
+4% +$20.3K ﹤0.01% 1720
2016
Q2
$431K Buy
137,450
+116,821
+566% +$366K ﹤0.01% 1698
2016
Q1
$69K Sell
20,629
-28,623
-58% -$95.7K ﹤0.01% 2146
2015
Q4
$173K Buy
49,252
+498
+1% +$1.75K ﹤0.01% 1655
2015
Q3
$245K Sell
48,754
-23,675
-33% -$119K ﹤0.01% 1584
2015
Q2
$465K Buy
72,429
+3,477
+5% +$22.3K ﹤0.01% 1530
2015
Q1
$485K Buy
68,952
+32,225
+88% +$227K ﹤0.01% 1505
2014
Q4
$283K Sell
36,727
-10,137
-22% -$78.1K ﹤0.01% 1416
2014
Q3
$350K Buy
46,864
+9,947
+27% +$74.3K ﹤0.01% 1375
2014
Q2
$357K Sell
36,917
-39
-0.1% -$377 ﹤0.01% 1358
2014
Q1
$308K Buy
36,956
+5,036
+16% +$42K ﹤0.01% 1414
2013
Q4
$270K Buy
31,920
+27,060
+557% +$229K ﹤0.01% 1497
2013
Q3
$39K Hold
4,860
﹤0.01% 1928
2013
Q2
$38K Buy
+4,860
New +$38K ﹤0.01% 1968